- Cyclooxygenase-2 Inhibitor Reduces Hepatic Stiffness in Pediatric Chronic Liver Disease Patients Following Kasai Portoenterostomy
-
Chang HK, Chang EY, Ryu S, Han SJ
- KMID: 2374120
- Yonsei Med J.
- 2016 Jul;57(4):893-899.
- doi: 10.3349/ymj.2016.57.4.893
PURPOSE: The purpose of this study was to define the role of cyclooxygenase-2 inhibitors (COX-2i) in reducing hepatic fibrosis in pediatric patients with chronic liver disease. MATERIALS AND METHODS: From September... -
- CITED
-
- Close
- SHARE
-
- Close
